Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Radiodermatitis 1 Immune System Diseases 1 Breast Neoplasms 1

Interventions

triethanolamine 1 calcipotriene 1 Triamcinolone Acetonide 1 Radiotherapy, Conformal 1 Radiotherapy 1 Melatonin 1 Dimethyl Sulfoxide 1 Curcumin 1 Biafine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Radiodermatitis × Dimethyl Sulfoxide × Clear all

NCT03716583 2021-09-10

MELADERM

Herlev Hospital

Phase 2 Completed

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡